Genetic Analysis AS enters into an agreement with Hausen Bernstein Co. Ltd.  to launch GA-map technology in Thailand |  MarketScreener

Genetic Analysis AS enters into an agreement with Hausen Bernstein Co. Ltd. to launch GA-map technology in Thailand | MarketScreener

OSLO, NORWAYNovember 30, 2022: Specialist in molecular diagnostics, AS genetic analysis (“GA”) has entered into a technology transfer and distribution agreement with Hausen Amber Co.Ltd. (“HB”), a bangkokfast-growing medical technology company with a diagnostic laboratory in bangkok and a diagnostic product distribution activity in Thailand. HB will launch the GA-map® dysbiosis test from its molecular laboratory in bangkok and market GA-map® products in a wider Thailand – making it the first standardized CE-IVD marked gut microbiome test in this market. The service offer will mainly target private and public clinical laboratories and a commercial launch is planned for the first quarter of 2023.

Ronny HermansenCEO, Genetic Analysis, comments:
“GA is proud to have Hausen Bernstein as a partner in Thailand and is delighted to see that our GA card ® the platform is recognized by customers around the world. The GA card® offers a rapid lab testing service with an integrated software algorithm for immediate presentation of the results of your microbiome analysis. The GA card ® will enable Hausen Bernstein to provide the highest quality microbiome testing in Thailand“.

The market demand for gut microbiome assessments is rapidly increasing globally in private health services, medical clinics and academic research with emphasis on identification and categorization of patient dysbiosis. In collaboration with HB, GA can now offer its CE-IVD marked standardized gut microbiome testing platform to the Thai market to meet the growing interest and awareness of dysbiosis.

Dr AS Hausen Bernstein, CEO, comments:
“HB is excited to bring the GA-map Microbiome Testing Platform to the Thai market, as we see the focus on our microbiome balance increasing rapidly as people experience more and more health-related issues. ‘gut. GA-map will be a great addition to our growing food allergy testing business. HB’s core value is to provide the highest quality products to our customers, and we are proud to add GA-map map to our premium product portfolio.

For more information, please contact:Ronny HermansenChief executive officer

Eilert AamodtFinancial director

About Hausen Amber Co.Ltd.:
Hausen Bernstein Co was founded in 2003 and is a rapidly growing medical technology company focused on providing the highest quality products, services and technical support to the Thai healthcare system. Hausen Bernstein also distributes the products of more than 20 renowned suppliers of EuropeUnited States, Japan, Singaporeand China. On the diagnostic side (IVD), products cover areas such as autoimmune diseases, allergy diagnostic tests, point-of-care tests for respiratory infections, gastrointestinal diseases, intolerance tests food and vector-borne diseases. Also, molecular diagnostic tests in infectious diseases and cancer diagnosis. In addition to IVD products, Hausen Bernstein offers unique medical devices for the health and wellness sector. Hausen Bernstein products are positioned as the most standard products in every field, and its customers are the top-ranked healthcare units in Thailand, medical schools, renowned private hospitals, hospital chains and private laboratories. The sales team covers the entire territory of Thailand.

For more information:

About genetic analysis:
AS genetic analysis (GA) is a scientific and pioneering human microbiome diagnostics company with more than 10 years of expertise in research and product development. The unique GA-map® platform is based on a specialized pre-determined multiplex target approach for the simultaneous analysis of large numbers of bacteria in a single reaction. Test results are generated using the state-of-the-art clinically validated GA-map® software algorithm. This allows immediate results to be obtained without the need for additional bioinformatics work. GA’s vision is to become the leading company in standardized gut microbiota testing worldwide, and GA is committed to helping unlock and restore the human microbiome through its cutting-edge technology. GA employs a team of highly qualified employees with scientific training and skills in bioinformatics, molecular biology and bioengineering.

Want to know more about GA products? Please visit–ltd–to-launch-ga-map- -technology-,c3675026

(c) Decision 2022. All rights reserved., sources Press Releases – English

#Genetic #Analysis #enters #agreement #Hausen #Bernstein #launch #GAmap #technology #Thailand #MarketScreener

Leave a Comment

Your email address will not be published. Required fields are marked *